Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Fuchs

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Neurology|February 1, 2013
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complicationsAlexander Storch, Christine B Schneider, Martin Wolz, et al.
Archives of Neurology|May 16, 2007
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson diseaseAlexander Storch, Wolfgang H Jost, Peter Vieregge, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's diseaseChristine B Schneider, Maximilian Pilhatsch, Martina Rifati, et al.
Archives of Neurology|May 22, 2002
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimenHorst Przuntek, Stefan Bittkau, Harald Bliesath, et al.
Clinical Neuropharmacology|July 4, 2014
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropiniroleKarla Eggert, Christian Öhlwein, Jan Kassubek, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Neurology|February 1, 2013
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complicationsAlexander Storch, Christine B Schneider, Martin Wolz, et al.
Archives of Neurology|May 16, 2007
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson diseaseAlexander Storch, Wolfgang H Jost, Peter Vieregge, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's diseaseChristine B Schneider, Maximilian Pilhatsch, Martina Rifati, et al.
Archives of Neurology|May 22, 2002
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimenHorst Przuntek, Stefan Bittkau, Harald Bliesath, et al.
Clinical Neuropharmacology|July 4, 2014
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropiniroleKarla Eggert, Christian Öhlwein, Jan Kassubek, et al.
Pageof 2